🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the firms concealed potential risks that the drug created to children's cognitive development.

This legal action arrives thirty days after President Donald Trump advocated an unsubstantiated connection between taking Tylenol - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is filing suit against Johnson & Johnson, which previously sold the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he stated they "deceived the public by profiting off of suffering and marketing drugs without regard for the dangers."

Kenvue asserts there is no credible evidence connecting acetaminophen to autism.

"These manufacturers deceived for years, deliberately risking countless individuals to line their pockets," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its website, Kenvue also said it had "consistently assessed the applicable studies and there is lacking reliable evidence that demonstrates a established connection between using acetaminophen and autism spectrum disorder."

Associations speaking for doctors and healthcare providers share this view.

ACOG has declared paracetamol - the main ingredient in Tylenol - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can pose serious health risks if left untreated.

"In over twenty years of research on the utilization of paracetamol in gestation, zero credible investigations has conclusively proven that the consumption of paracetamol in any trimester of gestation results in brain development issues in young ones," the group said.

The court filing references recent announcements from the former administration in asserting the medication is reportedly hazardous.

In recent weeks, the former president caused concern from public health officials when he advised expectant mothers to "fight like hell" not to take acetaminophen when ill.

The FDA then released a statement that physicians should consider limiting the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in children has remains unverified.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would determine the cause of autism spectrum disorder in a matter of months.

But authorities warned that identifying a unique factor of autism - believed by scientists to be the result of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism is a category of enduring cognitive variation and impairment that impacts how persons perceive and interact with the world, and is diagnosed using doctors' observations.

In his court filing, Paxton - a Trump ally who is seeking US Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the firms "remove any promotional materials" that claims Tylenol is reliable for women during pregnancy.

The court case mirrors the complaints of a collection of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

A federal judge threw out the case, saying studies from the parents' expert witnesses was lacking definitive proof.